바이오모아 (BioMoa) — ADC · Antibody

9103프로그램 35FDA 승인

0오늘 방문

1,401누적 방문

7846갱신 대기 S–CData Tier S/A/B차세대 1048HER2 breast 5318Antibody 2737CGT →Psoriasis →NSCLC 35FDA 승인

피드 Data Tier 차세대

최근 활동

RSS →

ADCBiologicstalePrimelink BioTherapeitics(ShenZ…Phase 1

PLB-002 (PLB-002)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

AntibodystaleColumbia UniversityPhase 1

131I-apamistmab (131I-apamistmab)

Sickling Disorder Due to Hemoglobin S · Sickling Disorder Due to Hemoglobin S

#SicklingDisorderDuetoHemoglobinS#Antibody#Phase1#항체#면역항체+2

임상시험 1상태 RECRUITING

ADCBiologicstaleAstraZenecaPhase 2

AZD0516 (AZD0516)

Metastatic Prostate Cancer · Metastatic Prostate Cancer

#MetastaticProstateCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

AntibodystaleJanssenPhase 3

Induction dose of (Induction dose of, Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin)

Hepatitis C, Chronic · Hepatitis C, Chronic

#HepatitisCChronic#Antibody#Phase3#항체#면역항체+4

임상시험 1상태 ACTIVE

AntibodystaleJanssenApproved

Palmitoleic Acid + Infliximab (Palmitoleic Acid + Infliximab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Approved#항체#면역항체+2

임상시험 1상태 RECRUITING

ADCBiologicstaleChangchun GeneScience Pharmaceu…Phase 1

GenSci139 (GenSci139)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

ADCBiologicstaleNovelty Nobility, Inc.Phase 1

NN3201 (NN3201)

Gastrointestinal Stromal Tumors; Small-cell Lung Cancer · Gastrointestinal Stromal Tumors

#GastrointestinalStromalTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

AntibodystaleSichuan Kelun-Biotech Biopharma…Phase 1

Drug: Tagitanlimab Drug: Capecitabine (Drug: Tagitanlimab Drug: Capecitabine)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase1#항체#면역항체+2

임상시험 1상태 RECRUITING

ADCBiologicstaleBioNTech SEPhase 2

BNT329 (BNT329)

Advanced Solid Cancers · Advanced Solid Cancers

#AdvancedSolidCancers#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

ADCBiologicstaleExelixisPhase 1

XB002 (XB002)

Non Small Cell Lung Cancer; Cervical Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 ACTIVE

AntibodystaleJanssenPhase 3

Infliximab plus methotrexate (Infliximab plus methotrexate)

Juvenile Idiopathic Arthritis · Juvenile Idiopathic Arthritis

#JuvenileIdiopathicArthritis#Antibody#Phase3#항체#면역항체+2

임상시험 1상태 ACTIVE

ADCBiologicstaleSorrento Therapeutics, Inc.Phase 1

STI-3258 (STI-3258)

Relapsed Solid Neoplasm; Refractory Cancer · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3

임상시험 1상태 DISCONTINUED

ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 1

FZ-AD004 (FZ-AD004)

Advanced and Metastatic Solid Tumor · Advanced and Metastatic Solid Tumor

#AdvancedandMetastaticSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

ADCBiologicstaleBioNTech SEPhase 1

BNT116 (BNT116)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

ADCBiologicstaleNovartis PharmaceuticalsPhase 1

NJH395 (NJH395)

NON-breast HER2+ Malignancies · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 ACTIVE

ADCBiologicstaleEDDC (Experimental Drug Develop…Phase 1

EBC-129 (EBC-129)

Advanced Solid Tumours · Advanced Solid Tumours

#AdvancedSolidTumours#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

ADCBiologicstaleBioAtla, Inc.Phase 2

Ozuriftamab Vedotin (Ozuriftamab Vedotin)

Head and Neck Cancer; Squamous Cell Carcinoma of Head and Neck · Head and Neck Cancer

#HeadandNeckCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 ACTIVE

ADCBiologicstaleBioNTech SEPhase 1

BNT316 (BNT316)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

ADCBiologicstaleZymeworks BC Inc.Phase 1

ZW251 (ZW251)

Hepatocellular Carcinoma; Squamous Cell Non-Small Cell Lung Cancer · Hepatocellular Carcinoma

#HepatocellularCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

ADCBiologicstaleBioNTech SEPhase 1

ALK-inhibitor or RET-inhibitor (ALK-inhibitor or RET-inhibitor)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

ADCBiologicstaleConjupro Biotherapeutics, Inc.Phase 1

CPO102 (CPO102)

Pancreatic Cancer; Gastric Cancer · Pancreatic Cancer

#PancreaticCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 DISCONTINUED

ADCBiologicstaleAdcendo ApSPhase 1

ADCE-B05 (ADCE-B05)

Solid Tumors (Phase 1) · Solid Tumors (Phase 1)

#SolidTumorsPhase1#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

ADCBiologicstaleOrum Therapeutics USA, Inc.Phase 1

ORM-5029 (ORM-5029)

HER2-positive Breast Cancer; HER-2 Protein Overexpression · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3

임상시험 1상태 DISCONTINUED

ADCBiologicstaleKyntra BioPhase 2

FG-3246 (FG-3246)

Metastatic Castration-Resistant Prostate Cancer · Metastatic Castration-Resistant Prostate

#MetastaticCastration-ResistantPr#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 1상태 RECRUITING

ADCBiologicstaleSeagen Inc.Phase 2

docetaxel (Taxotere, Taxotere (docetaxel))

Prostatic Neoplasms · Prostatic Neoplasms

#ProstaticNeoplasms#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 22.7%임상시험 1상태 ACTIVE

110 / 165 페이지

← 이전 다음 →

전체 9,103개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 0 / 1,401

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

PLB-002 (PLB-002)

131I-apamistmab (131I-apamistmab)

AZD0516 (AZD0516)

Induction dose of (Induction dose of, Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin)

Palmitoleic Acid + Infliximab (Palmitoleic Acid + Infliximab)

GenSci139 (GenSci139)

NN3201 (NN3201)

Drug: Tagitanlimab Drug: Capecitabine (Drug: Tagitanlimab Drug: Capecitabine)

BNT329 (BNT329)

XB002 (XB002)

Infliximab plus methotrexate (Infliximab plus methotrexate)

STI-3258 (STI-3258)

FZ-AD004 (FZ-AD004)

BNT116 (BNT116)

NJH395 (NJH395)

EBC-129 (EBC-129)

Ozuriftamab Vedotin (Ozuriftamab Vedotin)

BNT316 (BNT316)

ZW251 (ZW251)

ALK-inhibitor or RET-inhibitor (ALK-inhibitor or RET-inhibitor)

CPO102 (CPO102)

ADCE-B05 (ADCE-B05)

ORM-5029 (ORM-5029)

FG-3246 (FG-3246)

docetaxel (Taxotere, Taxotere (docetaxel))

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

PLB-002 (PLB-002)

131I-apamistmab (131I-apamistmab)

AZD0516 (AZD0516)

Induction dose of (Induction dose of, Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin)

Palmitoleic Acid + Infliximab (Palmitoleic Acid + Infliximab)

GenSci139 (GenSci139)

NN3201 (NN3201)

Drug: Tagitanlimab Drug: Capecitabine (Drug: Tagitanlimab Drug: Capecitabine)

BNT329 (BNT329)

XB002 (XB002)

Infliximab plus methotrexate (Infliximab plus methotrexate)

STI-3258 (STI-3258)

FZ-AD004 (FZ-AD004)

BNT116 (BNT116)

NJH395 (NJH395)

EBC-129 (EBC-129)

Ozuriftamab Vedotin (Ozuriftamab Vedotin)

BNT316 (BNT316)

ZW251 (ZW251)

ALK-inhibitor or RET-inhibitor (ALK-inhibitor or RET-inhibitor)

CPO102 (CPO102)

ADCE-B05 (ADCE-B05)

ORM-5029 (ORM-5029)

FG-3246 (FG-3246)

docetaxel (Taxotere, Taxotere (docetaxel))

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

PLB-002 (PLB-002)

131I-apamistmab (131I-apamistmab)

AZD0516 (AZD0516)

Induction dose of (Induction dose of, Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin)

Palmitoleic Acid + Infliximab (Palmitoleic Acid + Infliximab)

GenSci139 (GenSci139)

NN3201 (NN3201)

Drug: Tagitanlimab Drug: Capecitabine (Drug: Tagitanlimab Drug: Capecitabine)

BNT329 (BNT329)

XB002 (XB002)

Infliximab plus methotrexate (Infliximab plus methotrexate)

STI-3258 (STI-3258)

FZ-AD004 (FZ-AD004)

BNT116 (BNT116)

NJH395 (NJH395)

EBC-129 (EBC-129)